BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35589736)

  • 1. Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS/MS technique.
    Hosseinkhani S; Arjmand B; Dilmaghani-Marand A; Mohammadi Fateh S; Dehghanbanadaki H; Najjar N; Alavi-Moghadam S; Ghodssi-Ghassemabadi R; Nasli-Esfahani E; Farzadfar F; Larijani B; Razi F
    Sci Rep; 2022 May; 12(1):8418. PubMed ID: 35589736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016.
    Taghizadeh H; Emamgholipour S; Hosseinkhani S; Arjmand B; Rezaei N; Dilmaghani-Marand A; Ghasemi E; Panahi N; Dehghanbanadaki H; Ghodssi-Ghassemabadi R; Najjar N; Asadi M; Khoshniat M; Larijani B; Razi F
    Front Endocrinol (Lausanne); 2023; 14():1058952. PubMed ID: 36923214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC-MS/MS based metabolomics approach.
    Hosseinkhani S; Salari P; Bandarian F; Asadi M; Shirani S; Najjar N; Dehghanbanadaki H; Pasalar P; Razi F
    BMC Endocr Disord; 2022 Jul; 22(1):186. PubMed ID: 35864499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score.
    Dehghanbanadaki H; Dodangeh S; Parhizkar Roudsari P; Hosseinkhani S; Khashayar P; Noorchenarboo M; Rezaei N; Dilmaghani-Marand A; Yoosefi M; Arjmand B; Khalagi K; Najjar N; Kakaei A; Bandarian F; Aghaei Meybodi H; Larijani B; Razi F
    Front Cardiovasc Med; 2023; 10():1161761. PubMed ID: 37206107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis.
    Jabbar Al-Rikabi SA; Etemadi A; Morad MM; Nowrouzi A; Panahi GS; Mondeali M; Toorani-Ghazvini M; Nasli-Esfahani E; Razi F; Bandarian F
    Endocrinol Diabetes Metab; 2024 May; 7(3):e00484. PubMed ID: 38739122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
    Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
    Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DI/LC-MS/MS-Based Metabolome Analysis of Plasma Reveals the Effects of Sequestering Agents on the Metabolic Status of Dairy Cows Challenged with Aflatoxin B
    Ogunade I; Jiang Y; Pech Cervantes A
    Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31779109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications.
    Li X; Li Y; Liang Y; Hu R; Xu W; Liu Y
    Diabetes Metab J; 2021 Mar; 45(2):195-208. PubMed ID: 33685035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
    Roy C; Tremblay PY; Bienvenu JF; Ayotte P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the association between amino acid and acylcarnitine profiles and different levels of coronary artery disease risk in postmenopausal women using targeted metabolomics technique.
    Hosseinkhani S; Emamgholipour S; Salari P; Khalagi K; Shirani S; Najjar N; Larijani B; Pasalar P; Razi F
    Menopause; 2022 Sep; 29(9):1062-1070. PubMed ID: 35969879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
    Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
    Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population.
    Gunther SH; Khoo CM; Tai ES; Sim X; Kovalik JP; Ching J; Lee JJ; van Dam RM
    BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33004401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An observational and Mendelian randomization study of the associations of body mass index with plasma amino acids and acylcarnitines in Chinese adults].
    Cheng S; Wu T; Yu CQ; Sun DJY; Pei P; Du HD; Chen JS; Chen ZM; Pang YJ; Lyu J; Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Jun; 45(6):770-778. PubMed ID: 38889975
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
    Bailin SS; Jenkins CA; Petucci C; Culver JA; Shepherd BE; Fessel JP; Hulgan T; Koethe JR
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):536-543. PubMed ID: 29607651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.
    Wang F; Sun L; Sun Q; Liang L; Gao X; Li R; Pan A; Li H; Deng Y; Hu FB; Wu J; Zeng R; Lin X
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):560-568. PubMed ID: 29519950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Study for Investigation of Plasma Amino Acid Profile in Neurofibromatosis Type 1 Patients.
    Oz O; Koyuncu I; Gonel A
    Comb Chem High Throughput Screen; 2022; 25(1):114-122. PubMed ID: 33280590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum.
    Wang M; Yang R; Dong J; Zhang T; Wang S; Zhou W; Li H; Zhao H; Zhang L; Wang S; Zhang C; Chen W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():144-51. PubMed ID: 26735710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of acylcarnitines are altered in prediabetic conditions.
    Mai M; Tönjes A; Kovacs P; Stumvoll M; Fiedler GM; Leichtle AB
    PLoS One; 2013; 8(12):e82459. PubMed ID: 24358186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot data analysis of a metabolomic HPLC-MS/MS study of patients with COPD.
    Novotna B; Abdel-Hamid M; Koblizek V; Svoboda M; Hejduk K; Rehacek V; Bis J; Salajka F
    Adv Clin Exp Med; 2018 Apr; 27(4):531-539. PubMed ID: 29943523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues.
    Giesbertz P; Ecker J; Haag A; Spanier B; Daniel H
    J Lipid Res; 2015 Oct; 56(10):2029-39. PubMed ID: 26239049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.